Probabilistic Steering of Generative Priors for Lab-in-the-Loop Antibody Optimization
Therapeutic antibody development is often framed as comprising two discrete stages: initial discovery of novel binders followed by iterative optimization to refine these hits into therapeutic-grade molecules.
By Anisha Parsan, Sebastian Ober, Calvin McCarter, Nick Bhattacharya, Hunter ElliottarXiv cs.LG
Read the full story
Originally published by arXiv cs.LG on Nov 5, 2026.
Comments
Sign in to join the discussion.